Related Experiment Videos
Serobiological differentiation between antischistosomal (Schistosoma mansoni) antisera
Tropenmedizin Und Parasitologie
|March 1, 1981
Summary
Antibodies against schistosomula parasites have distinct roles. Cytotoxic antibodies in vitro do not guarantee passive protection, suggesting different antibodies mediate these antischistosomal activities.
Area of Science:
- Immunology
- Parasitology
- Molecular Biology
Background:
- Schistosomiasis is a significant human parasitic disease.
- Understanding immune responses is crucial for vaccine development.
- Antibody functions in schistosomiasis immunity require further elucidation.
Purpose of the Study:
- To differentiate between in vitro cytotoxic antibody activity and passive protective immunity against Schistosoma parasites.
- To investigate the role of antibodies targeting modified schistosomula.
- To explore the antigenic hierarchy of treatment-resistant determinants.
Main Methods:
- Sera from infected and immunized mice were tested for cytotoxicity against schistosomula.
- Indirect fluorescent antibody (IFA) technique was used with unmodified and modified schistosomula (heat, pronase).
- Passive protection assays were conducted.
Main Results:
- Both infected and immunized sera showed in vitro cytotoxicity and similar IFA titers with unmodified schistosomula.
- Only sera from infected mice conferred passive protection and reacted with modified schistosomula.
- Modified schistosomula induced antibodies with distinct IFA reactivity patterns.
Conclusions:
- In vitro cytotoxicity and passive protectivity are distinct antischistosomal activities.
- Quantitatively or qualitatively different antibodies likely mediate these functions.
- The role of antibodies to treatment-resistant determinants in protection requires further investigation.